The two studies were titled, “Open vs. Minimally Invasive Sacroiliac Joint Fusion: a Multi-Center Comparison of Perioperative Measures and Clinical Outcomes,” and “Safety and 6-Month Effectiveness of Minimally Invasive Sacroiliac Joint Fusion: A Prospective Study.”
The first study looked at patients who underwent either an open surgical procedure or a minimally invasive procedure with the iFuse system. The iFuse patients had significantly greater pain relief than those traditionally-treated.
The second study evaluated the implant’s safety and effectiveness. IFuse patients showed a 49 point improvement from baseline in VAS at six months and a 15.8 point decrease in Oswestry Disability Index. No revisions or removals were necessary.
More Articles on Devices:
Steven McAllister to Serve as InVivo Interim CFO
FDA Committee Calls for Class 3 Device Designation on Spinal Sphere Devices
3-D Printing for Medical Devices to Grow 15.4% Over 6 Years to $965M
